IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 878
EU - Europa 706
AS - Asia 492
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 876
SG - Singapore 461
IE - Irlanda 323
SE - Svezia 193
IT - Italia 118
RU - Federazione Russa 22
DE - Germania 19
VN - Vietnam 12
CN - Cina 8
UA - Ucraina 7
GB - Regno Unito 6
IN - India 5
BR - Brasile 4
CZ - Repubblica Ceca 4
FI - Finlandia 4
PL - Polonia 4
RO - Romania 4
EU - Europa 3
CA - Canada 2
ID - Indonesia 2
TH - Thailandia 2
BE - Belgio 1
LT - Lituania 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 2.084
Salva come PNG Salva come JPEG
Città #
Singapore 414
Dublin 323
Princeton 172
Santa Clara 108
Altamura 90
Jacksonville 79
Wilmington 56
Chandler 22
Norwalk 15
Dong Ket 12
Munich 8
Chicago 6
London 6
New York 5
Brno 4
Hangzhou 4
Helsinki 4
Romola 4
Ashburn 3
Nanjing 3
Andover 2
Chieti 2
Fairfield 2
Florence 2
Frankfurt am Main 2
Massarosa 2
Milan 2
Nuremberg 2
Phuket 2
Secaucus 2
Toronto 2
Auckland 1
Boardman 1
Bonn 1
Brussels 1
Camerino 1
Council Bluffs 1
Furth im Wald 1
Istanbul 1
Jiaxing 1
Laurel 1
Mountain View 1
Philadelphia 1
Pune 1
Redmond 1
Redwood City 1
Rome 1
San Mateo 1
Sant'Eusanio del Sangro 1
Washington 1
Woodbridge 1
Totale 1.380
Salva come PNG Salva come JPEG
Nome #
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 48
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 46
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 42
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 41
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 41
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 40
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 40
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 39
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 38
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 38
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 37
Prognostic factors in primary and iterative surgery of colorectal liver metastases 37
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 35
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 35
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 35
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 33
Cellular pharmacology of gemcitabine 33
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 33
Chronic inflammation in urothelial bladder cancer 33
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 33
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 33
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 33
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 32
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 32
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 32
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 32
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 32
Genomic and genetic alterations infuence the progression of gastric cancer 32
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 32
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 31
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 30
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 30
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 30
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 29
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 29
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 29
Druggable targets in pancreatic adenocarcinoma 29
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 28
Emerging drugs in refractory colorectal cancer 28
Role of ATP-binding cassette transporters in cancer initiation and progression 27
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 27
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 27
Pharmacogenetics: Implementing personalized medicine 27
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 27
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 27
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 26
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 26
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 26
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 26
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 26
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 26
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 25
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 25
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 25
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 25
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 24
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 23
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 23
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 23
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 23
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 23
Pharmacological strategies for overcoming multidrug resistance 23
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 22
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 22
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 22
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 22
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 22
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 22
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 21
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 21
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 21
Natural compounds for cancer treatment and prevention 21
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 21
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 21
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 20
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 20
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 19
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 19
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 19
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 19
Size dependent biological profiles of PEGylated gold nanorods 19
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 19
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 18
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 18
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 18
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 16
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 15
Maintenance in gastric cancer: New life for an old issue? 15
Totale 2.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 138 227 13 8 14 13 14 27
2021/2022214 1 4 3 2 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/2025892 103 464 295 11 19 0 0 0 0 0 0 0
Totale 2.432